SCHEMBL5403753

SCHEMBL5403753

Cc1cccc(CNC(=O)c2ccccc2-c2ccccc2C(=O)N(CCC(=O)O)CCc2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
KDM4E B2RXH2 1/20 0.53
HSD17B10 Q99714 1/20 0.53
RAB9A P51151 5/20 0.48
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
PPARG P37231 4/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
MAPK1 P28482 1/20 0.43
MMP13 P45452 1/20 0.43
LPAR1 Q92633 1/20 0.42
NPC1 O15118 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 2/20 0.41
ESR1 P03372 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5413978 0.97 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL5402281 0.95 HPGD (0.52) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL5418615 0.94 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL5409793 0.93 RAB9A (0.54) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL5399641 0.91 HPGD (0.48) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL5404109 0.91 LTB4R (0.46) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL5403109 0.91 CA2 (0.49) ALDH1A1HPGDKDM4EHSD17B10KMT2A
SCHEMBL5392954 0.91 KMT2A (0.52) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL5393982 0.91 RAB9A (0.56) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL5409471 0.91 RAB9A (0.62) ALDH1A1HPGDKDM4EHSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB ALDH1A1 1256/4885HPGD 1078/4885KDM4E 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.